EDGAR Filing Documents for 0001193125-17-179784

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

SEC Accession No. 0001193125-17-179784

Filing Date

2017-05-23

Accepted

2017-05-23 17:00:04

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3/A	d385151ds3a.htm	S-3/A	52955
2	EX-23.1	d385151dex231.htm	EX-23.1	1431
	Complete submission text file	0001193125-17-179784.txt		55425

Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746

Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935

Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)